ArticleProceedings (Baylor University. Medical Center)2023
Avapritinib for the treatment of KIT mutation-negative systemic mastocytosis.
Farhan Azad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it